Abstract
Abstract:
The present disclosure relates to a crystalline forms of 3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoic acid and process for their preparation.
Further, the present disclosure provides a pharmaceutical composition comprising Acoramidis or a pharmaceutically acceptable salt thereof.
The structure of Acoramidis is shown as below formula 1.
Formula-1
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center, Srinivasan Thirumalai Rajan, Sagyam Rajeshwar Reddy, Revu Satyanarayana, Kommera Rajasekhar, Keshavareddy Navin Kumar Reddy, Parigi Raghavendar Reddy, Garai Abhijit, Yata Murali, Mayandi Ramesh, "Crystalline forms of 3-[3-(3,5-dimethyl-1H-pyrazol-4-yl) propoxy]-4-fluorobenzoic acid and its use in the pharmaceutical compositions", Technical Disclosure Commons, (September 07, 2026)
https://www.tdcommons.org/dpubs_series/11629